BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6397281)

  • 1. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
    Asai K; Asai M
    Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate.
    Hitomi Y; Kanda T; Niinobe M; Fujii S
    Clin Chim Acta; 1982 Mar; 119(3):157-64. PubMed ID: 6461438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
    Frantzen Handeland G; Abildgaard U; Aasen AO
    Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved assay of antithrombin-III. Effects of certain additives on thrombin and on chromogenic peptide substrates.
    Gram J; Jespersen J
    Clin Chem; 1985 Oct; 31(10):1683-8. PubMed ID: 4042332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma.
    Hafner G; Fickenscher K; Friesen HJ; Rupprecht HJ; Konheiser U; Ehrenthal W; Lotz J; Prellwitz W
    Thromb Res; 1995 Jan; 77(2):165-73. PubMed ID: 7740508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated antithrombin-III assays by synthetic substrate on the Multistat III.
    Bick RL; Wheeler A
    Am J Clin Pathol; 1987 Aug; 88(2):192-7. PubMed ID: 3618551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
    van Voorthuizen H; Kluft C
    Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
    Lourenço DM; Noguti MA; Juliano L
    Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of colorimetric, fluorometric and spectrophotometric methods for measuring antithrombin III using synthetic substrates].
    Uete T
    Rinsho Byori; 1984 Nov; 32(11):1258-62. PubMed ID: 6520982
    [No Abstract]   [Full Text] [Related]  

  • 15. Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl.
    Scully MF; Kakkar VV
    Clin Chim Acta; 1977 Sep; 79(3):595-602. PubMed ID: 70286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses.
    Darien BJ; Potempa J; Moore JN; Travis J
    Vet Res Commun; 1989; 13(1):31-46. PubMed ID: 2773304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a rapid and sensitive chromogenic heparin assay for clinical use.
    Wagenvoord RJ; Hendrix HH; Kolde HJ; Hemker HC
    Haemostasis; 1993; 23(1):26-37. PubMed ID: 8477906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays.
    Goodnight SH; Schaeffer JL; Sheth K
    Am J Clin Pathol; 1980 May; 73(5):639-47. PubMed ID: 7377131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.